DK0967975T3 - Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre - Google Patents

Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre

Info

Publication number
DK0967975T3
DK0967975T3 DK98902707T DK98902707T DK0967975T3 DK 0967975 T3 DK0967975 T3 DK 0967975T3 DK 98902707 T DK98902707 T DK 98902707T DK 98902707 T DK98902707 T DK 98902707T DK 0967975 T3 DK0967975 T3 DK 0967975T3
Authority
DK
Denmark
Prior art keywords
inhibiting
degradation
methods
lewis acid
ether compositions
Prior art date
Application number
DK98902707T
Other languages
Danish (da)
English (en)
Inventor
Christopher Bieniarz
Keith R Cromack
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Rajagopalan Raghavan
Earl R Speicher
Honorate A Stelmach
Steve H Chang
Original Assignee
Abbott Lab
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0967975(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab, Central Glass Co Ltd filed Critical Abbott Lab
Application granted granted Critical
Publication of DK0967975T3 publication Critical patent/DK0967975T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
DK98902707T 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre DK0967975T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
PCT/US1998/001376 WO1998032430A1 (fr) 1997-01-27 1998-01-23 Compositions de fluoroether et procedes d'inhibition de leur degradation en presence d'un acide de lewis

Publications (1)

Publication Number Publication Date
DK0967975T3 true DK0967975T3 (da) 2001-09-17

Family

ID=25148366

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01107733T DK1114641T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
DK98902707T DK0967975T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK01107733T DK1114641T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre

Country Status (28)

Country Link
US (6) US5990176A (fr)
EP (2) EP0967975B1 (fr)
JP (5) JP3183520B2 (fr)
KR (1) KR100368672B1 (fr)
CN (3) CN1152674C (fr)
AR (2) AR011090A1 (fr)
AT (2) ATE201987T1 (fr)
AU (1) AU726733B2 (fr)
BG (2) BG65414B1 (fr)
BR (1) BR9806996A (fr)
CA (2) CA2626424A1 (fr)
CO (1) CO4920220A1 (fr)
CZ (1) CZ297092B6 (fr)
DE (2) DE69833884T2 (fr)
DK (2) DK1114641T3 (fr)
ES (2) ES2256104T3 (fr)
GR (1) GR3036190T3 (fr)
HK (1) HK1074434A1 (fr)
HU (1) HUP0002101A3 (fr)
IL (1) IL130150A (fr)
NO (1) NO993606L (fr)
NZ (1) NZ335994A (fr)
PL (1) PL334477A1 (fr)
PT (2) PT1114641E (fr)
SK (1) SK284243B6 (fr)
TR (1) TR199901579T2 (fr)
WO (1) WO1998032430A1 (fr)
ZA (1) ZA98418B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6162443A (en) 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
ATE252889T1 (de) * 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
EP1705852B1 (fr) 1999-01-08 2010-02-10 Sony Deutschland Gmbh Structure de symboles pour système MDFO
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
ATE365034T1 (de) * 2003-09-10 2007-07-15 Cristalia Prod Quimicos Farm Stabile pharmazeutische zusammensetzung einer fluorether-verbindung für die anästhesie, verfahren zur stabilisierung einer fluorether- verbindung, verwendung eines stabilisierungsmittels zum ausschluss des abbaus einer fluorether-verbindung
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
EA011936B1 (ru) * 2005-04-18 2009-06-30 Минрад Инк. Получение севофлурана с незначительным содержанием воды
WO2009049460A1 (fr) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. Nouveau matériau conditionné de sévoflurane
WO2009094459A1 (fr) * 2008-01-22 2009-07-30 The Board Of Regents Of The University Of Texas System Compositions anesthésiques volatiles comprenant des solvants d'extraction pour une anesthésie régionale et/ou un soulagement de la douleur
US20090275785A1 (en) * 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
CA2952552C (fr) * 2016-11-02 2018-05-15 Central Glass Company, Limited Methode de lavage de contenant de stockage de sevoflurane et methode de stockage de sevoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−１，１，１，３，３，３−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
EP1114641A3 (fr) 2003-05-28
SK86199A3 (en) 2000-06-12
US5990176A (en) 1999-11-23
JP3664648B2 (ja) 2005-06-29
CN1321958C (zh) 2007-06-20
AU726733B2 (en) 2000-11-16
CN1152674C (zh) 2004-06-09
PT967975E (pt) 2001-11-30
CA2278133A1 (fr) 1998-07-30
JP2005279283A (ja) 2005-10-13
JP2006143742A (ja) 2006-06-08
IL130150A0 (en) 2001-03-19
NO993606L (no) 1999-09-24
EP1114641A2 (fr) 2001-07-11
CN1899271A (zh) 2007-01-24
US6444859B2 (en) 2002-09-03
BR9806996A (pt) 2000-03-14
KR100368672B1 (ko) 2003-01-24
HUP0002101A2 (hu) 2001-05-28
US20060148906A1 (en) 2006-07-06
CN1244797A (zh) 2000-02-16
EP0967975B1 (fr) 2001-06-13
ES2170474T3 (es) 2002-08-01
US20020016373A1 (en) 2002-02-07
BG103656A (en) 2000-04-28
SK284243B6 (sk) 2004-12-01
ATE320798T1 (de) 2006-04-15
AR011090A1 (es) 2000-08-02
AU5930098A (en) 1998-08-18
BG109751A (bg) 2008-06-30
AR057610A2 (es) 2007-12-05
US20030130359A1 (en) 2003-07-10
DE69833884D1 (de) 2006-05-11
CO4920220A1 (es) 2000-05-29
CA2626424A1 (fr) 1998-07-30
BG65414B1 (bg) 2008-07-31
CA2278133C (fr) 2001-06-26
DE69800928T2 (de) 2001-11-22
JP3183520B2 (ja) 2001-07-09
PT1114641E (pt) 2006-05-31
US20040048932A1 (en) 2004-03-11
JP2006137769A (ja) 2006-06-01
EP1114641B1 (fr) 2006-03-22
GR3036190T3 (en) 2001-10-31
HK1074434A1 (en) 2005-11-11
CZ297092B6 (cs) 2006-09-13
ATE201987T1 (de) 2001-06-15
ES2256104T3 (es) 2006-07-16
CZ256199A3 (cs) 1999-11-17
TR199901579T2 (xx) 1999-12-21
US6677492B2 (en) 2004-01-13
US6288127B1 (en) 2001-09-11
PL334477A1 (en) 2000-02-28
NO993606D0 (no) 1999-07-23
HUP0002101A3 (en) 2002-03-28
IL130150A (en) 2004-09-27
ZA98418B (en) 1999-04-20
KR20000070482A (ko) 2000-11-25
JP2001187729A (ja) 2001-07-10
NZ335994A (en) 2000-08-25
WO1998032430A1 (fr) 1998-07-30
DK1114641T3 (da) 2006-05-15
CN1560003A (zh) 2005-01-05
JP2000510159A (ja) 2000-08-08
DE69833884T2 (de) 2006-08-24
DE69800928D1 (de) 2001-07-19
EP0967975A1 (fr) 2000-01-05

Similar Documents

Publication Publication Date Title
DK0967975T3 (da) Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre
DK0921923T3 (da) Beskyttelse af rørledningsforbindelser
NO991676L (no) FremgangsmÕter og sammensetninger for immunmodulering
DE69942666D1 (de) Intraluminaler stent
NO972030L (no) Grenstent og fremgangsmåte for dens fremstilling
DK1280026T3 (da) System for inspektion, evaluering og administration af anlæg
DE69727617D1 (de) Stent
DK199901813A (da) Forbedret fremgangsmåde til fortætning af naturgas
DE69838121D1 (de) Abzweigender Stent-Transplantat
DE69732349D1 (de) Expandierbarer stent
DK0886501T3 (da) Ekspanderbar stent
EE9900422A (xx) Stent
EE9900449A (xx) Stent
NO20025480L (no) Utvidbar stent
DE69723941D1 (de) Selbstexpandierende Endoprothese
DE69704134D1 (de) Schnellrohrverbindung
DE69916913T2 (de) Härtbare Flourpolyetherzusammensetzungen
DK0929331T3 (da) System og fremgangsmåde til tildeling af to væsker
DK1084363T3 (da) Fremgangsmåde til dannelse af en forgrening til et rör og tilslutning i et rör
DK0634383T3 (da) Fremgangsmåde til addition af HF til halogeneredealkener
DK70896A (da) Fremgangsmåde og anlæg til fremstilling af spiseispinde
NO975073D0 (no) Lavtoksisk korrosjonshemmer
DK0811324T3 (da) Fremgangsmåde og indretning til fremstilling af frosne sammensætninger indeholdende stykker
DE69811119D1 (de) Konferenzeinrichtung
DE69917739D1 (de) Expandierbarer stent